共 50 条
- [1] TWO-YEAR ADMINISTRATION DATA OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION IN HYPOGONADAL MEN JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S128 - S128
- [2] Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety JOURNAL OF SEXUAL MEDICINE, 2022, 19 (12): : 1750 - 1758
- [3] SAFETY ANALYSIS OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION FOLLOWING 2 YEARS OF ADMINISTRATION IN HYPOGONADAL MEN JOURNAL OF UROLOGY, 2021, 206 : E369 - E370
- [5] SALIVA AND SERUM TESTOSTERONE FOLLOWING ORAL TESTOSTERONE UNDECANOATE ADMINISTRATION IN NORMAL AND HYPOGONADAL MEN ACTA ENDOCRINOLOGICA, 1983, 102 (03): : 456 - 462
- [7] SAFETY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITRATION ALGORITHMS JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 150 - 150
- [9] PHARMACOKINETICS AND EFFICACY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITIRATION ALGORITHMS JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 112 - 113
- [10] Reexamination of Pharmacokinetics of Oral Testosterone Undecanoate in Hypogonadal Men With a New Self-Emulsifying Formulation JOURNAL OF ANDROLOGY, 2012, 33 (02): : 190 - 201